The Role of Renin-Angiotensin System in Progressive Renal Injury.
- Author:
Kang Wook LEE
1
;
Jung Hun SONG
;
Min Kyu KANG
;
Pyung Joo HWANG
;
Jong Hak KIM
;
Ki Ryang NA
;
Kwang Sun SUH
;
Jung Kyu PARK
;
Young Tai SHIN
Author Information
1. Department of Internal Medicine, College of Medicine, Chungnam National University, Taejeon, Korea. kwlee@hanbat.chungnam.ac.kr
- Publication Type:Original Article
- Keywords:
Renin-angiotensin system;
Angiotensin converting enzyme inhibitor;
Angiotensin II AT1 receptor antagonist;
5/6 nephrectomy;
Cytokine;
Renal injury
- MeSH:
Angiotensin Amide;
Angiotensin II;
Angiotensins;
Animals;
Blood Pressure;
Capillaries;
Cytokines;
Drinking Water;
Enalapril;
Endothelin-1;
Filtration;
Gene Expression;
Interleukin-6;
Losartan;
Osteopontin;
Peptidyl-Dipeptidase A;
Plasma;
Proteinuria;
Rats;
Renin;
Renin-Angiotensin System*;
Transforming Growth Factor beta;
Tumor Necrosis Factor-alpha
- From:Korean Journal of Nephrology
2001;20(3):413-426
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Angiotensin II(A II) -a main effector molecule of renin-angiotensin system(RAS) has been known to increase blood pressure and glomerular capillary pressure, and filtration fraction which may be involved in the progressive renal injury process. The action of A II takes place mainly through AT1 receptor. RAS can be blocked by angiotensin converting enzyme inhibitor(ACEI) and recently developed A II AT1 receptor antagonist(AT1 RA). ACEI also activate kinin system, simultaneously. However, AT1 RA does not affect kinin system. The renoprotective mechanism of ACEI may be related with activation of kinin system. In order to evaluate the renoprotective mechanism of long-term ACEI(enalapril, 100mg/L in drinking water for 12 weeks) or AT1 RA treatment(losartan 300mg/L in drinking water for 12 weeks), and its effect on the cytokines and growth factor expressions of renal cortical tissue by compatitive RT-PCR, 46 5/6 nephrectomized(5/6 NPX) rats and 8 sham operated rats were included in this study. Five sixth NPX rats showed marked hypertensin, significant proteinuria and glomerulosclerosis(mean 30.5%) in 12 weeks after surgery. However, enelapril or losartan treated rats revealed significantly lower 24 hour urinary protein excretion(UProtV), systolic blood pressure(SBP), and glomerulosclerosis than those of control 5/6 NPX rats. Plasma renin activity and angiotensin II levels of 5/6 NPX untreated control rats were not significantly increased compared to sham operated rats in 12 week after surgery. Renal cortical renin gene expression of untreated 5/6 NPX rats was significantly suppressed compared to sham operated rats. Enalapril or losartan treated 5/6 NPX rats showed significantly increased renin gene expression compared to untreated 5/6 NPX rats. Renal cortical gene expressions of TGF-beta, TNF-alpha, MCP-1, IL-6, osteopontin, and endothelin-1 were significantly increased in 5/6 NPX untreated control rats compared to sham operated rats. Enalapril or losartan treated 5/6 NPX rats showed significantly less level of renal TGF-beta gene expression compared to 5/6 NPX control rats. The magnitude of SBP and UProtV were significantly positively correlated with the degree of glomeruloslerosis(p<0.001, p<0.001). With the above result, we speculate that because ACEI or AT1 RA showed similar renoprotective effect in 5/6 NPX rats, at least in part, local activation of RAS plays an important role in the progressive renal injury process of this model.
